Compound ID | 561
Class: Fluoroquinolone
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Against Gram positves resistant to quinolones (including MRSA and S. epidermidis), Y-688 is more active than ofloxacin, ciprofloxacin, tosufloxacin and sparfloxacin |
Description: | Yokoyama Y, Morimoto M, Iwao E, et al. Y-688, a new fluoroquinolone with high activity against quinolone resistant Gram positive bacteria. 35th-Intersci-Conf-Antimicrobial-Agents-Chemother 1995; 146 |
Institute where first reported: | Yoshitomi Pharmaceuticals (Mitsubishi Pharma Corp., Japan) |
Year first mentioned: | 1995 |
Highest developmental phase: | Preclinical |
Development status: | Inactive |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/9887640 |
Citations: |
|